Estuardo Aguilar-Cordova
Founder presso CANDEL THERAPEUTICS, INC.
Patrimonio netto: 22 M $ in data 30/04/2024
Provenienza dei contatti di primo grado di Estuardo Aguilar-Cordova
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 29 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Estuardo Aguilar-Cordova tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| CARDINAL HEALTH, INC. | Medical Distributors | Director/Board Member Corporate Officer/Principal | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| IMMUNOGEN, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| SIGA TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer General Counsel Comptroller/Controller/Auditor Corporate Officer/Principal | |
| SANOFI | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Pear Tree Pharmaceuticals, Inc.
 Pear Tree Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pear Tree Pharmaceuticals, Inc. operates as a development stage company with interests in developing prescription products for women. It offers products that treat and prevent diseases, symptoms, and conditions associated with menopause and cancer chemotherapy. The company was founded by Stephen Charles Rocamboli, Fred H. Mermelstein, Janet Chollet and Martin J. Driscoll in July 2007 and is headquartered in Auburndale, MA. | Pharmaceuticals: Major | Founder Founder | |
Gen9, Inc.
 Gen9, Inc. BiotechnologyHealth Technology Gen9, Inc. engages in the development of synthetic biology technologies. It transforms synthetic biology by creating technologies to increase innovation within several industries including biopharmaceuticals, fine chemicals and bio-fuels. The company was founded by Joseph M. Jacobson, George Church and Drew Endy in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Presage Biosciences, Inc.
 Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Chief Executive Officer | |
Cornovus Pharmaceuticals, Inc.
 Cornovus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cornovus Pharmaceuticals, Inc. manufactures and wholesales pharmaceutical products. The company is headquartered in Farmington, CT. | Pharmaceuticals: Major | Chairman | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Corporate Officer/Principal | |
| City University of New York | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Doctorate Degree | |
| Yale University | College/University | Graduate Degree Undergraduate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
Foundation Fighting Blindness Clinical Research Institute
 Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Foundation Fighting Blindness Clinical Research Institute provides investment services. The company is headquartered in Columbia, MD. | Financial Conglomerates | Director/Board Member | |
| OPKO HEALTH, INC. | Medical/Nursing Services | Director/Board Member | |
Keystone Symposia
 Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Keystone Symposia operates as a catalyst for the advancement of biomedical and life sciences by connecting scientists within and across disciplines at conferences and workshops. The company was founded by C. Fred Fox in 1972 and is headquartered in Silverthorne, CO. | Miscellaneous Commercial Services | Chairman | |
| The Presidential Advisory Council on HIV/AIDS | General Government | Corporate Officer/Principal | |
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| Rhone-Poulenc Canada, Inc. | President | ||
University of Virginia Community Credit Union
 University of Virginia Community Credit Union Savings BanksFinance University of Virginia Community Credit Union operates as a state chartered credit union. The private company is based in Charlottesville, VA and has subsidiaries in the United States. | Savings Banks | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
PBM Capital Group LLC
 PBM Capital Group LLC Investment ManagersFinance PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia. | Investment Managers | Chief Executive Officer Corporate Officer/Principal | |
| Harvard College | College/University | Undergraduate Degree | |
| ADVANZ PHARMA CORP. LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Xalud Therapeutics, Inc.
 Xalud Therapeutics, Inc. BiotechnologyHealth Technology Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA. | Biotechnology | Chairman Chief Executive Officer | |
| VERRICA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
UVA Health Foundation
 UVA Health Foundation Internet Software/ServicesTechnology Services Part of University of Virginia, UVA Health Foundation operates a healthcare platform. The private company is based in Charlottesville, VA. | Internet Software/Services | Director/Board Member | |
Viking Scientific, Inc.
 Viking Scientific, Inc. Pharmaceuticals: MajorHealth Technology Viking Scientific, Inc. operates as a preclinical stage drug delivery company which engages in the develop of controlled release products. It uses drugs as building blocks to create biodegradable polymers with customizable properties. The company was founded in 2015 and is headquartered in San Marcos, CA. | Pharmaceuticals: Major | Director/Board Member | |
| TFF PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Translational Sciences, Inc.
 Translational Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Translational Sciences, Inc. is an American company that researches, develops, and manufactures cardiovascular drugs. | Miscellaneous Commercial Services | Chairman | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| ALX ONCOLOGY HOLDINGS INC. | Biotechnology | Corporate Officer/Principal | |
| Tibotec Therapeutics, Inc. | President | ||
Revival Healthcare Capital LLC
 Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018. The firm is headquartered in Austin, Texas. | Investment Managers | Consultant / Advisor | |
| CannaMetrix LLC | Director/Board Member | ||
Deck Therapeutics, Inc.
 Deck Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Deck Therapeutics, Inc. is an American acute omega-3 fatty acid therapeutics development company. Søren Weis Dahl has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 43 |
| Francia | 4 |
| Regno Unito | 3 |
| Svizzera | 2 |
| Canada | 2 |
Settori
| Health Technology | 26 |
| Consumer Services | 9 |
| Finance | 5 |
| Commercial Services | 4 |
| Government | 3 |
Posizioni
| Director/Board Member | 130 |
| Corporate Officer/Principal | 54 |
| Independent Dir/Board Member | 39 |
| Chairman | 36 |
| President | 36 |
Contatti più connessi
| Insiders | |
|---|---|
| Edward Benz | 29 |
| Joseph Papa | 28 |
| Paul Manning | 26 |
| Carrie Cox | 22 |
| Shaan Gandhi | 22 |
| Stephen Rocamboli | 20 |
| Fred H. Mermelstein | 16 |
| Paul-Peter Tak | 15 |
| Susan Stewart | 15 |
| Glenn Mattes | 15 |
| John J. Canepa | 13 |
| Diem Nguyen | 11 |
| Jason Amello | 11 |
| Alan Smith | 10 |
| Sandra E. Poole | 10 |
- Borsa valori
- Insiders
- Estuardo Aguilar-Cordova
- Connessioni Società
